RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) had its price target lowered by analysts at D. Boral Capital from $15.00 to $8.00. They now have a "buy" rating on the stock.
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
Reviva to Present Brilaroxazine Topline Data for Long-Term OLE Portion of RECOVER Study in Schizophrenia at 2025 SIRS Congress
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Reviva to Participate in the 2025 BIO CEO & Investor Conference
Form S-8 REVIVA PHARMACEUTICALS
Form 10-K REVIVA PHARMACEUTICALS For: Dec 31
Form NT 10-K REVIVA PHARMACEUTICALS For: Dec 31
Form 8-K REVIVA PHARMACEUTICALS For: Mar 31
Form 8-K REVIVA PHARMACEUTICALS For: Feb 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.